Search keyWord :

SoftBank Corp. and Fujitsu Strengthen Partnership for Realization of AI-RAN Commercialization

Nov 13, 2024

TOKYO and KAWASAKI,Japan,Nov. 13,2024-- SoftBank Corp. and Fujitsu Limited signed a memorandum of understanding on October 25,2024,to strengthen their partnership toward realizing the commercializatio

Caliway Announced EMA Orphan Drug Designation Granted to CBL-514 for Dercum's Disease Treatment

Nov 13, 2024

- CBL-514 is the first and only drug to receiveEMA Orphan Drug Designation for Dercum\'s disease treatment.

3rd Global Sustainable Rice Conference and Exhibition - Transforming Food, Climate, and People

Nov 13, 2024

Global Conference in Bangkok Invites Participants to Shape the Future of Sustainable Rice SINGAPORE,Nov. 13,2024-- The 3rd Global Sustainable Rice Conference & Exhibition 2024,will be held in Bang

Taipei City's "Global Pass" Program Empowers Startups to Enter Global Markets

Nov 13, 2024

TAIPEI CITY,Nov. 13,2024-- To support Taipei-based startups in taking on global expansion,the Taipei City Government has introduced the "Global Pass" program. This initiative offers up to 80

Thai Language Courses for Foreign Nationals at Chula

Nov 13, 2024

BANGKOK,Nov. 13,2024-- "Learning Thai language can open the door to new experiences and employment opportunities for foreigners living or traveling in Thailand," said Assistant Professor Dr.

Celebrate the Festive Season at Natra Bintan with Unforgettable Christmas and New Year's Eve Events

Nov 13, 2024

BINTAN ISLAND,Indonesia,Nov. 13,2024-- As the year draws to a close,there\'s no better time to celebrate the joy of the festive season than with loved ones by your side. Christmas and the New Year are

BLUETTI Unveils Elite 200 Portable Power Station Promising Over 17 Years of Dependable Charging

Nov 13, 2024

LAS VEGAS,Nov. 13,2024-- BLUETTI,a leader in portable power stations and eco-friendly energy solutions,launches the Elite 200 V2,a 2KWh all-powerful portable power station designed for easy and conve

A Phase I/II Clinical Study of Anti-HER2 Bispecific ADC Subcutaneous Co-formulation JSKN033 was Included in the Pilot Program for Optimizing the Review and Approval of Clinical Trials for Innovative Drugs

Nov 13, 2024

SUZHOU,China,Nov. 13,2024-- Alphamab Oncology (stock code: 9966.HK) announced that a clinical trial (Study ID: JSKN033-102) of JSKN033,a high-concentration subcutaneous co-formulation consisting of an

AJCCA Conference 2024 in Singapore - Strengthening Cybersecurity Alliances and Recognizing ACRA Achievements

Nov 13, 2024

-Enhancing Cybersecurity in the ASEAN region by Expanding Regional Alliances and Forging New Partnerships-

Millennium Hotels and Resorts Partners with Aiello to Revolutionize Hospitality with AI Voice Technology

Nov 13, 2024

Enhancing Guest Experience and Operational Efficiency with Cutting-Edge AI Solutions TAIPEI,Nov. 13,2024-- Aiello,a leading startup specializing in Natural Language Processing (NLP),is proud to announ

1 ... 809 810 811 812 813 814 815 ... 1244